Metrikler
Yayın
110
Açık Erişim
11
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1982 - 1988
1982 - 1988Lisans
Hacettepe Üniversitesi, Tıp, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2011 - Devam Ediyor
2011 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Kanser Enstitüsü, Klinik Onkolojisi A.B.D.
Yönetimsel Görevler
2014 - Devam Ediyor
2014 - Devam EdiyorAnabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Kanser Enstitüsü, Klinik Onkoloji Anabilim Dalı
2009 - 2013
2009 - 2013Enstitü Müdür Yardımcısı
Hacettepe Üniversitesi, Kanser Enstitüsü
2004 - 2013
2004 - 2013Anabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Kanser Enstitüsü, Prevantif Onkoloji Anabilim Dalı
Akademi Dışı Deneyim
2006 - 2007
2006 - 2007Misafir Öğretim Üyesi
Johns Hopkins University, Baltimore, USA, Misafir Öğretim Üyesi
Makaleler
Tümü (78)
SCI-E, SSCI, AHCI (71)
SCI-E, SSCI, AHCI, ESCI (73)
ESCI (2)
Scopus (69)
TRDizin (6)
Diğer Yayınlar (2)
2023
20231. Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey.
Cakir A., Elcin G., Kilickap S., Gököz Ö., Taskiran Z. E., Celik İ.
Dermatology practical & conceptual
, cilt.13, sa.3, 2023 (SCI-Expanded, Scopus)
2023
20232. Smoker Relatives of Inpatients: A Reasonable but Heterogeneous Target Population for Smoking Cessation Program
AKTAŞ B. Y., HÜSEYİN B., YÜCE D., DİZDAR Ö., ERMAN M., HAYRAN M., et al.
Archives of Basic and Clinical Research
, cilt.5, sa.1, ss.178-184, 2023 (TRDizin)
2021
20213. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
Karacin C., Eren T., Zeynelgil E., Imamoglu G. I., Altinbas M., Karadag I., et al.
FUTURE ONCOLOGY
, cilt.17, ss.4447-4456, 2021 (SCI-Expanded, Scopus)
2021
20214. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data
Ozdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.
INTERNATIONAL JOURNAL OF CANCER
, cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded, Scopus)
2021
20215. Metastatic cutaneous melanoma epidemiological registry in Turkey: A preliminary evaluation of diagnosis and treatment approaches
Karaca B. S., Sezer A., Goksu S. S., ÇİÇİN İ., Erdem D., ÇUBUKÇU E., et al.
JOURNAL OF TRANSLATIONAL MEDICINE
, cilt.19, 2021 (SCI-Expanded, Scopus)
2020
20206. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.2, ss.267-272, 2020 (SCI-Expanded, Scopus)
2019
20197. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
ÜRÜN Y., Yasar H. A., TURNA Z. H., Esin E., Sedef A. M., Alkan A., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.25, sa.7, ss.1658-1664, 2019 (SCI-Expanded, Scopus)
2019
20198. The role of ABO blood groups in glial neoplasms
Alkan A., YAZICI G., CENGİZ M., Karakas Y., ÇELİK İ., Kars A., et al.
BRITISH JOURNAL OF NEUROSURGERY
, cilt.33, sa.1, ss.43-46, 2019 (SCI-Expanded, Scopus)
2018
20189. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY AND RELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER
HAYRAN K. M., Yuce D., Kilickap S., Huseyin B., Erman M., Dizdar O., et al.
VALUE IN HEALTH
, cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)
2018
201810. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE
HAYRAN K. M., Yuce D., Kilickap S., Dizdar O., Huseyin B., Erman M., et al.
VALUE IN HEALTH
, cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)
2017
201711. BİR SİGARA BIRAKMA POLİKLİNİĞİNDE UYGULANAN PSİKOEĞİTİMSEL SİGARA BIRAKMA POROGRAMININ ETKİNLİĞİ
KAMIŞLI S., YÜCE D., küçükçoban ş., HAYRAN K. M., KILIÇKAP S., ÇELİK İ., et al.
Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi , cilt.20, sa.4, ss.234-242, 2017 (TRDizin)
2017
201712. Reinforcement of mental health in an interaction group of cancer patients
HAYRAN K. M., Kamisli S., Kucukcoban S., ÇELİK İ., KILIÇKAP S., YÜCE D.
PSYCHO-ONCOLOGY
, cilt.26, ss.161, 2017 (SCI-Expanded, SSCI, Scopus)
2016
201613. Beneficiation routes for upgrading iron ore tailings with a teetered bed separator
ÖZCAN Ö., ÇELİK İ.
SEPARATION SCIENCE AND TECHNOLOGY
, cilt.51, sa.17, ss.2844-2855, 2016 (SCI-Expanded, Scopus)
2015
201514. A Retrospective Study of 137 Dysplastic Nevi Are a Personal History of Melanoma and Histopathological Factors Associated with High grade Cytologic Atypia
DUMAN N., ERKİN G., GÖKÖZ Ö., KARAHAN S., KAYIKÇIOĞLU A. U., ÇELİK İ.
Journal of Cancer and Tumor International , cilt.2, sa.3, ss.110-116, 2015 (Hakemli Dergi)
2015
201515. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study
Abali H., ÇELİK İ., Karaca B., TURNA Z. H., Saglam E. K., Akman T., et al.
JOURNAL OF BUON
, cilt.20, sa.4, ss.1137-1141, 2015 (SCI-Expanded, Scopus)
2015
201516. QUALITY OF LIFE DOMAINS ASSOCIATED WITH READMISSION
HAYRAN K. M., YÜCE D., Huseyin B., Esin E., KILIÇKAP S., ERMAN M., et al.
VALUE IN HEALTH
, cilt.18, sa.3, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201517. Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter
Zoto T., KILIÇKAP S., YAŞAR Ü., ÇELİK İ., BOZKURT A., BABAOĞLU M. Ö.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.116, sa.4, ss.354-360, 2015 (SCI-Expanded, Scopus)
2015
201518. Nationwide Smoking Cessation Treatment Support Program - Turkey project
ÇELİK İ., YÜCE D., Hayran M., ERMAN M., KILIÇKAP S., BUZĞAN T., et al.
HEALTH POLICY
, cilt.119, sa.1, ss.50-56, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201519. Nevus-Associated versus de novo Melanoma: Do They Have Different Characteristics and Prognoses?
Duman N., Erkin G., GÖKÖZ Ö., KARAHAN S., Kayikcioglu A. U., ÇELİK İ.
DERMATOPATHOLOGY
, cilt.2, sa.1, ss.46-51, 2015 (ESCI)
2014
201420. HEALTH RELATED QUALITY OF LIFE IN CANCER PATIENTS: EVALUATION WITH A SELF-ADMINISTERED IPAD APPLICATION
YÜCE D., HAYRAN K. M., KILIÇKAP S., ERMAN M., ÇELİK İ.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201421. ASSOCIATION OF HEALTH CARE COST WITH QUALITY OF LIFE FOR VARIOUS TYPES OF CANCERS
HAYRAN K. M., YÜCE D., Huseyin B., Esin E., KILIÇKAP S., ERMAN M., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201422. Study of interaction with a group of cancer patients: guiding cancer patients through psychoeducational interventions
Kamisli S., HAYRAN K. M., Kucukcoban S., KILIÇKAP S., YÜCE D., ÇELİK İ.
EUROPEAN JOURNAL OF ONCOLOGY NURSING
, cilt.18, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201423. A Rare Variant of Melanoma Clinical Histopathological and Prognostic Features in 5 Cases of Animal Type Melanoma
DUMAN N., ERKİN G., GÖKÖZ Ö., KAYIKÇIOĞLU A. U., ÇELİK İ.
ACTA ONCOLOGICA TURCICA , cilt.47, sa.3, ss.20-25, 2014 (Hakemli Dergi)
2013
201324. Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience
Kutluk T., HAYRAN K. M., Kilickap S., Yuce D., Celik I., Erman M., et al.
JOURNAL OF BUON
, cilt.18, sa.4, ss.1088-1096, 2013 (SCI-Expanded, Scopus)
2013
201325. Mass Balance and Quantitative Mineralogy Studies for Circuit Modification
CAN N. M., ÇELİK İ., Bıçak Ö., Altun O.
MINERAL PROCESSING AND EXTRACTIVE METALLURGY REVIEW
, cilt.34, sa.5, ss.348-365, 2013 (SCI-Expanded, Scopus)
2013
201326. Multicentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 years
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
, cilt.11, ss.68-69, 2013 (SCI-Expanded, Scopus)
2013
201327. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience
KILIÇKAP S., BARIŞTA İ., ÜLGER Ş., ÇELİK İ., SELEK U., YILDIZ F., et al.
BALKAN MEDICAL JOURNAL
, cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201328. Bilateral Seqential Acral Lentiginous Melanoma of the Sole
Keskin O., ÇELİK İ., KARS S. A.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.276-277, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201229. Long-term complications in Hodgkin's lymphoma survivors
KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., SELEK U., Gullu I., et al.
TUMORI
, cilt.98, sa.5, ss.601-606, 2012 (SCI-Expanded, Scopus)
2011
201130. Multimodality Treatment in the Management of Anorectal Melanoma: A Case Report and Review of the Literature
Tapan U., DİZDAR Ö., Bulut N., ÇELİK İ.
EURASIAN JOURNAL OF MEDICINE
, cilt.43, sa.3, ss.189-191, 2011 (ESCI, TRDizin)
2011
201131. Frequency of comorbid illnesses in cancer patients in Turkey
Abali H., Ata A., Ozdogan M., Turhal S., Cabuk D., Seyrek E., et al.
JOURNAL OF BUON
, cilt.16, sa.3, ss.557-560, 2011 (SCI-Expanded, Scopus)
2011
201132. Influence of Process Mineralogy on Improving Metallurgical Performance of a Flotation Plant
ÇELİK İ., CAN N. M., Sherazadishvili J.
MINERAL PROCESSING AND EXTRACTIVE METALLURGY REVIEW
, cilt.32, sa.1, ss.30-46, 2011 (SCI-Expanded, Scopus)
2011
201133. FREQUENCY OF CANCER TYPES IN PATIENTS AGED 65 AND OLDER: RESULTS FROM CANCER REGISTRY DATABASE OF HACETTEPE UNIVERSITY HOSPITALS
Arslan C., KILIÇKAP S., Dede D. S., HAYRAN K. M., ERMAN M., ÇELİK İ., et al.
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI
, cilt.14, sa.3, ss.187-192, 2011 (SCI-Expanded, SSCI, Scopus, TRDizin)
2008
200834. Arsenic in drinking water and lung cancer: A systematic review
ÇELİK İ., Gallicchio L., Boyd K., Lam T. K., Matanoski G., Tao X., et al.
ENVIRONMENTAL RESEARCH
, cilt.108, sa.1, ss.48-55, 2008 (SCI-Expanded, Scopus)
2008
200835. Prognostic impact of bone turnover markers in multiple myeloma
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
200836. Erectile dysfunction in successfully treated lymphoma patients
AKSOY S., HARPUTLUOĞLU H., KILIÇKAP S., DİNÇER M., DİZDAR Ö., AKDOĞAN B., et al.
SUPPORTIVE CARE IN CANCER
, cilt.16, sa.3, ss.291-297, 2008 (SCI-Expanded, Scopus)
2008
200837. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance
Dizdar O., Erman M., Cankurtaran M., Halil M., Ulger Z., Yavuz B. B., et al.
ANNALS OF HEMATOLOGY
, cilt.87, sa.1, ss.57-60, 2008 (SCI-Expanded, Scopus)
2007
200738. Cancer in first-degree relatives: A cross-sectional study at a Turkish University
Hayran M., Senan S., Sengelen M., Erman M., Celik İ.
PSYCHO-ONCOLOGY
, cilt.16, sa.3, 2007 (SCI-Expanded, SSCI, Scopus)
2007
200739. Biochemical markers of bone turnover in diagnosis of myeloma bone disease
Dizdar O., Barista I., Kalyoncu U., Karadag O., Hascelik G., Cila A., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.82, sa.3, ss.185-191, 2007 (SCI-Expanded, Scopus)
2007
200740. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: A comparison of efficacy, side-effect profile, and cost
Abali H., Celik I.
CANCER INVESTIGATION
, cilt.25, sa.3, ss.135-139, 2007 (SCI-Expanded, Scopus)
2006
200641. L-2-hydroxyglutaric aciduria and brain tumors: Report of two patients with medulloblastoma and glioblastoma
Haliloglu G., Celik I., Karli O. K., Anlar B., Ozisik P., Akalan N., et al.
JOURNAL OF INHERITED METABOLIC DISEASE
, cilt.29, ss.53, 2006 (SCI-Expanded, Scopus)
2006
200642. Acrocyanosis as a presenting symptom of Hodgkin lymphoma
Solak Y., Aksoy S., Kilickap S., Celik I.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.81, sa.2, ss.151-152, 2006 (SCI-Expanded, Scopus)
2005
200543. Association of the ABCB1 3435C > T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists
Babaoglu M., Bayar B., Aynacioglu A., Kerb R., Abali H., Celik I., et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS
, cilt.78, sa.6, ss.619-626, 2005 (SCI-Expanded, Scopus)
2005
200544. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis
Guler N., Uckan S., Celik I., Oznurlu Y., Uckan D.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
, cilt.34, sa.8, ss.900-906, 2005 (SCI-Expanded, Scopus)
2005
200545. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
Kilickap S., Baristal I., Akgul E., Aytemir K., Aksoyek S., Aksoy S., et al.
ANNALS OF ONCOLOGY
, cilt.16, sa.5, ss.798-804, 2005 (SCI-Expanded, Scopus)
2005
200546. Cytarabine-induced fever complicating the clinical course of leukemia
GÖNEN C., Celik I., Cetinkaya Y., Haznedaroglu I.
ANTI-CANCER DRUGS
, cilt.16, sa.1, ss.59-62, 2005 (SCI-Expanded, Scopus)
2004
200447. CA 19-9 measurement as a screening: Higher cost, lower survival
Kilickap S., Abali H., Aksoy S., Celik I.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, cilt.19, sa.12, ss.1428, 2004 (SCI-Expanded, Scopus)
2004
200448. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
Erman M., Abali H., ORAN B., Haznedaroglu I., Canpinar H., KİRAZLI Ş., et al.
ANNALS OF ONCOLOGY
, cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded, Scopus)
2004
200449. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia
Altundag O., Altundag K., Celik I., Turker A., Kars A.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.75, sa.4, ss.263-264, 2004 (SCI-Expanded, Scopus)
2004
200450. Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behcet's disease
Ozturk M., Ertenli I., Kiraz S., Haznedaroglu I., Celik I., Kirazli S., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.24, sa.2, ss.98-102, 2004 (SCI-Expanded, Scopus)
2004
200451. Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women - A case-control study
ORAN B., Celik I., Erman M., BALTALI E., ZENGİN N., Demirkazik F., et al.
MEDICAL ONCOLOGY
, cilt.21, sa.1, ss.31-39, 2004 (SCI-Expanded, Scopus)
2003
200352. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus)
2003
200353. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis
Calguneri M., Apras S., Ozbalkan Z., Ertenli I., Kiraz S., Ozturk M., et al.
CLINICAL RHEUMATOLOGY
, cilt.22, ss.289-294, 2003 (SCI-Expanded, Scopus)
2003
200354. Bevacizumab, bleeding, thrombosis, and warfarin
Kilickap S., Abali H., Celik I.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.21, sa.18, ss.3542, 2003 (SCI-Expanded, Scopus)
2003
200355. Pathologic thrombopoiesis of rheumatoid arthritis
Ertenli I., Kiraz S., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.
RHEUMATOLOGY INTERNATIONAL
, cilt.23, sa.2, ss.49-60, 2003 (SCI-Expanded, Scopus)
2003
200356. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors
Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.
TUMORI
, cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus)
2003
200357. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis
Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Calguneri M., Atalar E., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.30, sa.2, ss.313-315, 2003 (SCI-Expanded, Scopus)
2002
200258. High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel
Abali H., Celik I.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.25, sa.6, ss.632-633, 2002 (SCI-Expanded, Scopus)
2002
200259. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients
Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.
CHEMOTHERAPY
, cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus)
2002
200260. Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report
Baltahi E., Altundag M., Onat D., Abbasoglu O., Ozisik Y., Guler N., et al.
TUMORI J
, cilt.88, sa.6, ss.474-477, 2002 (SCI-Expanded, Scopus)
2002
200261. Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis
Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Kirazli S., et al.
CLINICAL RHEUMATOLOGY
, cilt.21, sa.6, ss.453-456, 2002 (SCI-Expanded, Scopus)
2002
200262. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel
Engin H., Celik I.
CLINICAL ONCOLOGY
, cilt.14, sa.2, ss.178, 2002 (SCI-Expanded, Scopus)
2002
200263. 5,7,7,8,10-Pentabromo-7,8-dihydrobenzocyclooctene
Çelik I., Tutar A., Akkurt M., Özcan Y., Çakmak O.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS
, 2002 (SCI-Expanded)
2002
200264. Pineal germ cell tumor metastasis via ventriculoperitoneal shunt
Altundag O., Celik I., Kars A.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.25, sa.1, ss.104-105, 2002 (SCI-Expanded, Scopus)
2002
200265. Central nervous system bleeding as a first manifestation of immunothrombocytopenic purpura in Hodgkin's disease
Engin H., Abali H., Erman M., Karaoglu A., Celik I., Guler N.
HAEMATOLOGIA
, cilt.31, sa.4, ss.373-375, 2002 (SCI-Expanded, Scopus)
2002
200266. Pathological haemostasis and 'prothrombotic state' in Behcet's disease
Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.
THROMBOSIS RESEARCH
, cilt.105, sa.2, ss.125-133, 2002 (SCI-Expanded, Scopus)
2002
200267. Dihydropyrimidine dehydrogenase enzyme deficiency: Clinical and genetic assessment of prevalence in Turkish cancer patients
Celik I., Kars A., Guc D., Tekuzman G., Ruacan S.
CANCER INVESTIGATION
, cilt.20, sa.3, ss.333-339, 2002 (SCI-Expanded, Scopus)
2001
200168. 2,2-exo-3,5,6-Pentabromobicycloheptane
Hokelek T., Celik I., TUTAR A., CAKMAK O.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
, cilt.57, 2001 (SCI-Expanded)
2000
200069. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.
JOURNAL OF SURGICAL ONCOLOGY
, cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)
2000
200070. Crystal structure of 2,2-exo-3,5,5-exo-6-hexabromobicycloheptane, C7H6Br6
Akkurt M., Celik I., Tutar A., Cakmak O., Ide S.
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES
, cilt.215, sa.4, ss.529-530, 2000 (SCI-Expanded, Scopus)
2000
200071. Crystal structure of 7-acetyl-5-benzoyl-6-phenyl-8-methyl-4,7-dihydropyrazolo[1,5-c]-1 H-pyrimidine-2-one
Celik I., Akkurt M., Ide S., Onal Z., Altural B.
ZEITSCHRIFT FUR KRISTALLOGRAPHIE
, cilt.215, sa.1, ss.48-51, 2000 (SCI-Expanded)
1998
199872. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever
KİRAZ S., ERTENLİ A. İ., ARICI M., Calguneri M., HAZNEDAROĞLU İ. C., ÇELİK İ., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.16, sa.6, ss.721-724, 1998 (SCI-Expanded, Scopus)
1998
199873. Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas
Celik İ., Kars A., Guler N., Barista I., Tekuzman G., Ozyilkan O., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.34, sa.5, ss.759-760, 1998 (SCI-Expanded, Scopus)
1997
199774. Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma
Kars A., Celik İ., Kansu E., Tekuzman G., Ozisik Y., Guler N., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.59, sa.2, ss.100-104, 1997 (SCI-Expanded, Scopus)
1997
199775. Timing of therapy in vasculitis-associated multiple myeloma: comment on the article by Hasegawa et al.
Topeli A., Barişta I., Celik İ., Kansu E.
Arthritis and rheumatism
, cilt.40, ss.395-6, 1997 (SCI-Expanded, Scopus)
1996
199676. Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity
Gursoy M., Haznedaroglu I., Celik İ., Sayinalp N., Ozcebe O., Dundar S.
ANNALS OF PHARMACOTHERAPY
, cilt.30, ss.762-765, 1996 (SCI-Expanded, Scopus)
1996
199677. Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients
Haznedaroglu I., Erdem Y., Celik İ., Sayinalp N., Dundar S., Caglar S., et al.
BLOOD PURIFICATION
, cilt.14, sa.3, ss.227-233, 1996 (SCI-Expanded, Scopus)
1995
199578. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
Celik İ., Akalin S., Erbaş T.
European journal of endocrinology
, cilt.132, sa.6, ss.668-72, 1995 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2021
20211. HACETTEPE’DE MELANOM TANISI ALAN HASTALARIN DEĞERLENDİRİLMESİ: 321 HASTAYA AİT RETROSPEKTİF TANIMLAYICI ÇALIŞMA
AKDOĞAN N., ELÇİN G., GÖKÖZ Ö., KONAŞ E., KILIÇKAP S., ÇELİK İ.
8. Ulusal Dermatolojik Cerrahi Günleri, Ankara, Türkiye, 18 Kasım 2021, (Özet Bildiri)
2018
20182. BİR ÜNİVERSİTENİN SİGARA BIRAKMA ÜNİTESİNE BAŞVURANLARIN ÖZELLİKLERİ VE SİGARA BIRAKMA OLASILIKLARI
ŞENGELEN M., ÇELİK İ., ERMAN M., Tezcan S., YÜCE D., Kamışlı S., et al.
2. ULUSLARARASI 20. ULUSAL HALK SAĞLIĞI KONGRESİ, Antalya, Türkiye, 13 - 17 Kasım 2018, (Özet Bildiri)
2018
20183. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE
HAYRAN K. M., YÜCE D., KILIÇKAP S., DİZDAR Ö., houssein b., ERMAN M., et al.
ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, (Özet Bildiri)
2018
20184. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY ANDRELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER
HAYRAN K. M., YÜCE D., KILIÇKAP S., houssein b., ERMAN M., DİZDAR Ö., et al.
ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, cilt.1, ss.11, (Tam Metin Bildiri)
2018
20185. Metastatic Choroidal Melanoma: Single Center Experience
AKTAŞ B. Y., GÜNER G., DEMİR M., GÜVEN D. C., AKTEPE O. H., BÖLEK E. Ç., et al.
2. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018, ss.1-48, (Tam Metin Bildiri)
2017
20176. Reinforcement of mental health in an interaction group of cancer patients
HAYRAN K. M., Kamışlı S., küçükçoban ş., ÇELİK İ., KILIÇKAP S., YÜCE D.
2017 World Congress of Psycho-Oncology, 14 - 18 Ağustos 2017, (Özet Bildiri)
2017
20177. Efficiency of a psychoeducational Intervention for smoking cessation in a specialized cessation clinic
YÜCE D., KAMIŞLI S., KÜÇÜKÇOBAN ş., HAYRAN K. M., KILIÇKAP S., ÇELİK İ., et al.
2017 World Congress of Psycho-Oncology, 14 - 18 Ağustos 2017, (Özet Bildiri)
2017
20178. Smoker relatives of inpatients: A reasonable but heterogeneous target population for smoking cessation program
AKTAŞ B. Y., HOUSSEİN b., YÜCE D., DİZDAR Ö., KILIÇKAP S., ERMAN M., et al.
7th ECTOH Conference on Tobacco or Health, Porto, Portekiz, 22 - 25 Mart 2017, (Özet Bildiri)
2016
20169. The role of ABO blood groups in glial neoplasia
Alkan A., Yazici G., Cengiz M., Celik I., Kars A., Zorlu F.
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27, (Özet Bildiri)
2016
201610. Using geographical information systems to describe quality of life as a function of distance in cancer patients
HAYRAN K. M., ERMAN M., KILIÇKAP S., DİZDAR Ö., YÜCE D., HÜSEYİN B., et al.
ISPOR Asia Pacific Meeting 2016, 3 - 06 Eylül 2016, cilt.19, ss.892, (Özet Bildiri)
2016
201611. Imaging the interactions between oral pathogens and probiotic lactic acid bacteria on the adhesion to human gingival fibroblast cells by confocal and fluorescein microscopy
Akca G., Celik I., Ermis M., Foto E.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.110-111, (Özet Bildiri)
2016
201612. ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN CHRONIC HEPATITIS B INFECTION PATIENTS IN TURKEY: A MULTICENTER STUDY
Karacaer Z., Cakir B., Erdem H., Ugurlu K., Durmus G., Ince N. K., et al.
EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, cilt.64, (Özet Bildiri)
2015
201513. Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study
Urun Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)
2015
201514. The survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: Final analysis of MIPI-TURK
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Mandel N. M., Demir G., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201515. Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey
Celik I., Mandel N. M., Gokmen E., Unal O. U., Sevinc A., Coskun H. S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2013
201316. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2012
201217. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2011
201118. MIPI-TURK - Multicentric Ipilimumab Experience in Turkish Patients With Metastatic Melanoma
Sevinc A., Ozdogan M., Buyukberber S., Aydin F., Mandel N. M., Demir O. G., et al.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
2010
201019. Relationship between genetic polymorphisms of multidrug resistance gene MDR1 (ABCB1) and clearance of 99mTc-MIBI
Kapulu-Akca C., Goktas M., Babaoglu M. O., Altundag K., Yasar U., Celik I., et al.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri)
2009
200920. Frequency of co-morbid illnesses in cancer patients in Turkey
Abali H., Ata A., Turhal S., Ozdogan M., Seyrek E., Erman M., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2006
200621. Influence of smoking history on breast cancer prognosis
Aksoy S., Ozisik Y., Guler N., Altundag K., Hayran M., Celik İ., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.101, (Özet Bildiri)
2006
200622. Cancer mortality trends in Turkey
Sengelen M., Senan S., Hayran M., Erman M., Celik İ.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.193, (Özet Bildiri)
2006
200623. Evaluation of the psychological distress among the oncology hospital personnel
Senan S., Sengelen M., Cakir B., Tezcan S., Hayran M., Erman M., et al.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.193-194, (Özet Bildiri)
2006
200624. Comparing relative cancer frequencies in the geriatric versus non-geriatric patients
Dede D. S., Hayran M., Erman M., Sengelen M., Senan S., Celik İ.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.160, (Özet Bildiri)
2006
200625. Gastric cancer in Turkey: Characteristics and etiology (a case control study of Turkish Oncology Group)
Icli F., Yalcin B., Ozdemir F., Isikdogan A., Celik I., Unsal D., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.324, (Özet Bildiri)
2006
200626. Cancer in the first-degree relatives: A cross-sectional study in a Turkish university
Hayran M., Senan S., Sengelen M., Erman M., Celik İ.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.192, (Özet Bildiri)
2006
200627. Increasing performance of a hospital-based cancer registry system - The Hacettepe University hospital experience
Hayran M., Erman M., Sengelen M., Senan S., Yurukel M., Yalcin S., et al.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.194, (Özet Bildiri)
2005
200528. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2004
200429. Increased Troponin-T level is associated with anthracycline-induced diastolic dysfunction of the left ventricle.
Kilickap S., Barista I., Akgul E., Aytemir K., Aksoyek S., Celik I., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
Kitaplar
2019
20191. TÜTÜNSÜZ ÜNİVERSİTE İÇİN ADIM ADIM UYGULAMA REHBERİ
ESER Z., SÖZEN F., DEMİR E., DEMİRCİ DURAN H., CANBUL D., AKER S., et al.
BAŞKENT ÜNİVERSİTESİ, 2019
Desteklenen Projeler
2015 - 2016
2015 - 2016
Etkileşim Gruplarında Kanser Hastalarının Başetmeleri
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
HAYRAN K. M. (Yürütücü), KILIÇKAP S., KAMIŞLI S., YÜCE D., ÇELİK İ., KÜÇÜKÇOBAN Ş.